Simplify Propel Opportunities ETF (SURI) Holdings
SURI holdings summary
as of Oct 23, 2026- Holdings
- 23 positions listed
- Top 10 weight
- 76.3% of net assets
- Effective holdings
- 3 equal-weight equivalent
- Largest holding
- PAGP 47.24% Plains GP Holdings, L.P.
- Annual turnover
- 44.3% of the portfolio traded
All SURI holdings
| # | Name | ||||||
|---|---|---|---|---|---|---|---|
| 1 | PAGP | Plains GP Holdings, L.P. | Energy | 47.24% | $34.9M | $6.40B | 62.4 |
| 2 | ACHV | Achieve Life Sciences, Inc. | Healthcare | 8.74% | $6.5M | $657.8M | — |
| 3 | DCTH | Delcath Systems, Inc. | Healthcare | 4.22% | $3.1M | $488.6M | — |
| 4 | MIST | Milestone Pharmaceuticals Inc. | Healthcare | 3.09% | $2.3M | $88.1M | — |
| 5 | CORT | Corcept Therapeutics Incorporated | Healthcare | 3.02% | $2.2M | $11.91B | 244.8 |
| 6 | COLL | Collegium Pharmaceutical, Inc. | Healthcare | 2.90% | $2.1M | $755.0M | 18.3 |
| 7 | PHAT | Phathom Pharmaceuticals, Inc. | Healthcare | 2.34% | $1.7M | $559.8M | — |
| 8 | OBIO | Orchestra BioMed Holdings, Inc. | Healthcare | 1.66% | $1.2M | $327.6M | — |
| 9 | ABEO | Abeona Therapeutics Inc. | Healthcare | 1.64% | $1.2M | $253.3M | — |
| 10 | KYTX | Kyverna Therapeutics, Inc. | Healthcare | 1.47% | $1.1M | $350.7M | — |
| 11 | CMPS | COMPASS Pathways plc | Healthcare | 1.44% | $1.1M | $1.49B | — |
| 12 | AQST | Aquestive Therapeutics, Inc. | Healthcare | 1.43% | $1.1M | $474.4M | — |
| 13 | IVA | Inventiva S.A. | Healthcare | 1.34% | $987,632.18 | $694.5M | — |
| 14 | CABA | Cabaletta Bio, Inc. | Healthcare | 1.08% | $802,261.67 | $239.1M | — |
| 15 | LONA | LeonaBio, Inc. | Healthcare | 1.01% | $748,728.27 | $49.0M | — |
| 16 | PROK | ProKidney Corp. | Healthcare | 0.96% | $709,021.86 | $530.9M | — |
| 17 | CLDX | Celldex Therapeutics, Inc. | Healthcare | 0.91% | $674,861.04 | $2.16B | — |
| 18 | PALI | Palisade Bio, Inc. | Healthcare | 0.82% | $608,092.17 | $245.7M | 2.4 |
| 19 | ARTV | Artiva Biotherapeutics, Inc. | Healthcare | 0.79% | $587,018.93 | $286.0M | — |
| 20 | OCUL | Ocular Therapeutix, Inc. | Healthcare | 0.68% | $504,056.94 | $1.51B | — |
| 21 | SABS | SAB Biotherapeutics, Inc. | Healthcare | 0.38% | $279,941.26 | $230.2M | — |
| 22 | CRVS | Corvus Pharmaceuticals, Inc. | Healthcare | 0.32% | $233,875.91 | $800.8M | — |
| 23 | IMUX | Immunic, Inc. | Healthcare | 0.30% | $219,309.50 | $95.1M | — |
Weights as a percentage of net assets. Value held = weight × net assets ($73.9M). Market cap and P/E from each company's latest fundamentals (U.S.-listed stocks).
SURI sector breakdown
Sum of the weights of the holdings in each sector.
SURI top industries
SURI overlap with other ETFs
| ETF | Fund | Overlap | Shared holdings | Expense ratio |
|---|---|---|---|---|
| IWM | iShares Russell 2000 ETF | 0.3% | 16 of 1,962 | 0.19% |
| VTI | Vanguard Total Stock Market ETF | 0.0% | 17 of 2,941 | 0.03% |
| VXUS | Vanguard Total International Stock ETF | 0.0% | 0 of 8,035 | 0.05% |
| SPY | SPDR S&P 500 ETF | 0.0% | 0 of 502 | 0.09% |
| QQQ | Invesco QQQ ETF | 0.0% | 0 of 101 | 0.17% |
| DIA | SPDR Dow Jones Industrial Average ETF | 0.0% | 0 of 30 | 0.16% |
Overlap = sum over shared holdings of the smaller of the two weights. 100% means identical portfolios.
About the SURI portfolio
Simplify Propel Opportunities ETF holds 23 positions. The ten largest make up 76.3% of the fund, so it behaves like a portfolio of about 3 equally weighted stocks. The biggest positions are Plains GP Holdings, L.P. (47.24%), Achieve Life Sciences, Inc. (8.74%), Delcath Systems, Inc. (4.22%), Milestone Pharmaceuticals Inc. (3.09%), Corcept Therapeutics Incorporated (3.02%).
By sector, Energy is 47.2%, Healthcare is 40.6%. Holdings data is from the fund's latest portfolio as reported by EODHD on October 23, 2026; positions change as the fund rebalances.
Related: SURI chart, SURI performance, SURI dividends, SURI overview.
SURI holdings FAQ
How many holdings does SURI have?
SURI holds 23 positions as of October 23, 2026.
What are the top 10 holdings of SURI?
The ten largest holdings are Plains GP Holdings, L.P. (47.24%), Achieve Life Sciences, Inc. (8.74%), Delcath Systems, Inc. (4.22%), Milestone Pharmaceuticals Inc. (3.09%), Corcept Therapeutics Incorporated (3.02%), Collegium Pharmaceutical, Inc. (2.90%), Phathom Pharmaceuticals, Inc. (2.34%), Orchestra BioMed Holdings, Inc. (1.66%), Abeona Therapeutics Inc. (1.64%), Kyverna Therapeutics, Inc. (1.47%). Together they are 76.3% of the fund.
What percentage of SURI is Plains GP Holdings, L.P.?
Plains GP Holdings, L.P. is the largest holding at 47.24% of net assets, about $34.9M of the fund's $73.9M.
How concentrated is SURI?
The top 10 holdings are 76.3% of the fund. By the effective number of holdings (1 divided by the sum of squared weights) SURI behaves like a portfolio of about 3 equally weighted stocks.